OBD — Oxford Biodynamics Income Statement
0.000.00%
Last trade - 00:00- £9.30m
- £10.18m
- £0.64m
Annual income statement for Oxford Biodynamics, fiscal year end - September 30th, GBP millions except per share, conversion factor applied.
R2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.456 | 0.341 | 0.154 | 0.51 | 0.636 |
| Cost of Revenue | |||||
| Gross Profit | — | — | 0.116 | 0.266 | 0.289 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 5.41 | 7.85 | 8.76 | 10.6 | 13.5 |
| Operating Profit | -4.95 | -7.51 | -8.6 | -10.1 | -12.9 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -4.95 | -7.63 | -7.57 | -11.4 | -12 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -4.35 | -6.68 | -6.71 | -10.8 | -11.6 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -4.35 | -6.68 | -6.71 | -10.8 | -11.6 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -4.35 | -6.68 | -6.71 | -10.8 | -11.6 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.047 | -0.072 | -0.067 | -0.074 | -0.043 |